Markets:

Overview

News

Currencies

International

Treasuries

Illumina, Inc. - Common Stock (NQ:ILMN)

292.19 +19.15 (+7.01%)

Delayed Quote Updated: 2:48 PM EDT, Oct 5, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Illumina, Inc. - Common Stock

< Previous 1 2

...

11 12 13 14 15 16 17 18 19

...

39 40 Next >

3 Stocks to Buy for the Age of Personalized Medicine ↗

January 28, 2024

Personalized medicine stocks can unlock significant growth from your portfolio. Here are three companies to consider.

Via InvestorPlace

Jim Cramer: Stay Away From This Major Airline Stock, 'People Should Understand Airlines Are Trades' ↗

January 24, 2024

On CNBC’s "Mad Money Lightning Round," Jim Cramer recommended to stay away from Delta Air Lines, Inc. (NYSE: DAL). "People should understand airlines are trades," he noted.

Via Benzinga

MarketBeat ‘Stock of the Week’: Intuitive Surgical hits new highs

January 22, 2024

With recent obesity drug fears proving to be overblown and equipment placements growing, expect ISRG to reward growth investors with plenty more record highs.

Via MarketBeat

Topics Earnings

The Top 3 Stocks in the High-Potential ‘Cancer Testing’ Market ↗

January 18, 2024

With the value of the cancer testing market expected to soar over the next decade, here are the three best disease testing stocks to buy now.

Via InvestorPlace

7 Mighty Healthcare Stocks Changing the Game of Medicine ↗

January 17, 2024

Thanks to the permanent relevance of medical innovations, investors ought to consider looking at these healthcare stocks.

Via InvestorPlace

Illumina Inc. (NASDAQ: ILMN) Highlighted for Surprising Price Action

January 09, 2024

Via Investor Brand Network

Why Illumina Rallied 36.6% in December ↗

January 09, 2024

The beaten-down gene sequencing company is getting a further shakeup.

Via The Motley Fool

Earnings Scheduled For February 8, 2024 ↗

February 08, 2024

Companies Reporting Before The Bell • Ares Management (NYSE:ARES) is expected to report quarterly earnings at $1.09 per share on revenue of $864.54 million.

Via Benzinga

Earnings Preview For Illumina ↗

February 07, 2024

Via Benzinga

The Top 25 Stocks to Buy Immediately According to AI: February 2024 Edition ↗

February 06, 2024

Some of the best stocks to buy in February according to MarketMaster AI suggest that a major economic recovery is underway.

Via InvestorPlace

Topics Artificial Intelligence

Fall in Love with ‘Galaxy 360: A Woman’s Playground’ this Valentine’s Day

February 06, 2024

Via Get News

Top Stock Picks 2024: 3 Healthcare Stocks Leading Medical Advancements ↗

February 01, 2024

Discover how emerging tech is shaping healthcare stocks in 2024. See which companies are outperforming and what it means for your portfolio.

Via InvestorPlace

Tuesday Talk: A Good Month - Two Days To Go ↗

January 30, 2024

With two trading days to go in January the major stock indices seem to be set to end the month at new highs and there are fewer analysts trying to insist that the

Via Talk Markets

(ILMN) - Analyzing Illumina's Short Interest ↗

January 26, 2024

Via Benzinga

Analyst Ratings For Illumina ↗

January 25, 2024

Via Benzinga

10 Health Care Stocks With Whale Alerts In Today's Session ↗

January 16, 2024

Via Benzinga

Biotech Playbook: Small Caps Show Momentum Peaking During ↗

January 15, 2024

The momentum of selected stocks was strong up until early January was encouraging but we need less volatility in period ahead to conform a new bull market.

Via Talk Markets

Why JetBlue Airways Shares Are Trading Lower By Over 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

January 09, 2024

Shares of JetBlue Airways Corporation (NASDAQ: JBLU) fell sharply during Tuesday’s session.

Via Benzinga

Deep Dive Into Illumina Stock: Analyst Perspectives (9 Ratings) ↗

January 04, 2024

Via Benzinga

10 Health Care Stocks Whale Activity In Today's Session ↗

January 09, 2024

Via Benzinga

Illumina Shares Trading Higher After Confirming Partnership With Johnson & Johnson Unit ↗

January 09, 2024

Illumina, Inc. (NASDAQ: ILMN) shares are trading higher after announcing preliminary financial results for the fourth quarter (Q4) and

Via Benzinga

Acuity Brands Posts Upbeat Earnings, Joins Accolade, Urban Outfitters And Other Big Stocks Moving Higher On Tuesday ↗

January 09, 2024

U.S. stocks traded lower, with the Dow Jones index falling over 250 points on Tuesday.

Via Benzinga

Topics Stocks

ILMN DEADLINE NOTICE: ROSEN, A LONGSTANDING LAW FIRM, Encourages Illumina, Inc. Investors to Secure Counsel Before Important January 9 Deadline in Securities Class Action - ILMN

January 08, 2024

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Topics Lawsuit

The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Illumina, Inc. (ILMN)

January 08, 2024

From The Law Offices of Frank R. Cruz

Via Business Wire

ILMN DEADLINE ALERT: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Illumina, Inc. Investors to Secure Counsel Before Important January 9 Deadline in Securities Class Action - ILMN

January 07, 2024

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Topics Lawsuit

ILLUMINA DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Illumina, Inc. and Encourages Investors to Contact the Firm

January 05, 2024

From Bragar Eagel & Squire

Via GlobeNewswire

ILMN FINAL DEADLINE ALERT: ROSEN, A LEADING LAW FIRM, Encourages Illumina, Inc. Investors to Secure Counsel Before Important January 9 Deadline in Securities Class Action – ILMN

January 05, 2024

From The Rosen Law Firm PA

Via GlobeNewswire

Illumina's MRD Technology For Cancer Testing Collaborates With Johnson & Johnson Unit ↗

January 05, 2024

Illumina, Inc. (NASDAQ: ILMN) announced it has signed an agreement with Janssen Research & Development, a unit of Johnson & Johnson (NYSE: JNJ).

Via Benzinga

ILLUMINA SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Illumina To Contact Him Directly To Discuss Their Options

January 05, 2024

From Faruqi & Faruqi LLP

Via GlobeNewswire

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Acelyrin, Illumina, and Roblox and Encourages Investors to Contact the Firm

January 02, 2024

From Bragar Eagel & Squire

Via GlobeNewswire

< Previous 1 2

...

11 12 13 14 15 16 17 18 19

...

39 40 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Illumina, Inc. - Common Stock (NQ:ILMN)

All News about Illumina, Inc. - Common Stock

Starting at /week.